Therapeutic Opportunities of IL-22 in Non-Alcoholic Fatty Liver Disease: From Molecular Mechanisms to Clinical Applications

Nonalcoholic fatty liver disease (NAFLD) represents one of the most common liver disorders and can progress into a series of liver diseases, including nonalcoholic steatohepatitis (NASH), fibrosis, cirrhosis, and even liver cancer. Interleukin-22 (IL-22), a member of the IL-10 family of cytokines, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Zai, Wenjing, Chen, Wei, Liu, Hongrui, Ju, Dianwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698419/
https://www.ncbi.nlm.nih.gov/pubmed/34944732
http://dx.doi.org/10.3390/biomedicines9121912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698419/
https://www.ncbi.nlm.nih.gov/pubmed/34944732
http://dx.doi.org/10.3390/biomedicines9121912

Ejemplares similares